#ontheroadwith EMMA International

by | May 14, 2017 | Uncategorized

Spring conference season is upon us and EMMA International has just finished an exciting month of conferences with some incredible organizations we work closely with. If you are not familiar with the Medical Device Manufacturers Association (MDMA), the Manufacturers Association of Central PA (MASCPA), the Food & Drug Law Institute (FDLI), and the Florida Medical Manufacturers Consortium (FMMC), they are all industry leading organizations that do incredible work in both the local and national space. The team at EMMA International wanted to take a moment to share some of the highlights from their annual conferences.

EMMA International was proud to be a Silver Sponsor of this year’s 2017 (MDMA) Annual Meeting. Congressman Erik Paulsen (MN), who has been the lead Republican sponsor of the medical device tax repeal legislation, led the opening remarks at the Opening Reception. At the Chairman’s Reception, the 2017 Leadership Award Winners were given to Congresswoman Elise Stefanik, Congresswoman Mimi Walters and Senator Todd Young. The 2017 Leadership Award Winners were selected based on their, “strong leadership in Congress on issues that promote patient care and innovations in the medical device industry and their efforts to ensure that the United States continues to be the lead producer of cutting-edge technologies and medical advancements”.

The Manufacturers Association of Central PA is the go to turnkey resource for manufacturing trade regionally, based in southcentral Pennsylvania. EMMA International was proud to be a Silver Sponsor of their 111th Annual Event.

As a Bronze Sponsor of this year’s 2017 Food & Drug Law Institute Annual Conference (FDLI), EMMA International ensures to be apprised of the latest policy developments, enforcement actions, and priority initiatives for 2017 from the FDA Acting Commissioner, Chief Counsel, Product Center Directors, and other key leadership. Additionally, EMMA International’s President and CEO, Dr. Carmine Jabri, led a facilitated table topic on Medical Devices & Cybersecurity.

For those of you who were able to attend the Florida Medical Device Consortium (FMMC) Annual Symposium, we hope you had the opportunity to attend the session titled “510(k) Updates: When and How to Work with the FDA on Device Modifications”, moderated by Jan Flegeau, Director of Global Regulatory Affairs at EMMA International. EMMA International was a Gold Sponsor at the symposium, which is considered to be Florida’s premier event for medical device manufacturing firms, featuring nationally recognized speakers, expert panels on regulatory issues and industry trends, legislative updates, exhibiting companies and quality networking opportunities.

 

Emma International

Emma International

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...
Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

Ready to learn more about working with us?

Pin It on Pinterest

Share This